دانلود کتاب مفاهیم فعلی در کاردیومیوپاتی آریتموژنیک
Current Concepts in Arrhythmogenic Cardiomyopathy 2nd Edition

Current Concepts in Arrhythmogenic Cardiomyopathy, Second Edition presents essential insights into all aspects of this complex disease and will serve as a valuable guide to help readers provide the best possible care for their patients.

Discussion by internationally recognized authorities includes: Increasing evidence that arrhythmogenic cardiomyopathy is not necessarily confined to the RV, but often involves both ventricles Basic and clinical science of arrhythmogenic cardiomyopathy Pathophysiology, molecular mechanisms, and genetic background The mechanisms of disease progression leading to a diversity of disease?phenotypes Guidance in the clinical setting for diagnosis, risk strati? fication, and therapy

Contents

۱. The History of Naxos Disease. Landmarks in the History of the Disorder
۲. Metabolic Deregulation in Arrhythmogenic Cardiomyopathy. Novel Pathogenic Insights and Th
۳. Pleiotropic Functions of Plakophilin-2 and Arrhythmia Mechanisms
۴. Immune Signaling in Arrhythmogenic Cardiomyopathy
۵. Studying Arrhythmogenic Cardiomyopathy Under the Microscope
۶. Genetic Contributions to Arrhythmogenic Cardiomyopathy
۷. Current Challenges in the Diagnosis of Arrhythmogenic Cardiomyopathies
۸. Differential Diagnosis of Phenotypic Variants of Arrhythmogenic Cardiomyopathy
۹. Life-Threatening Arrhythmias Without Overt Clinical Disease. “Concealed”Arrhythmogeni
۱۰. Genotype-Phenotype Correlations in ACM. The Chinese Experience
۱۱. Biomarkers in Inherited Arrhythmias. Arrhythmogenic Right Ventricular Cardiomyopathy and
۱۲. Atrial Fibrillation and ECG Markers of Atrial Involvement in Arrhythmogenic Right Ventri
۱۳. Medical Therapy in Arrhythmogenic Right Ventricular Cardiomyopathy
۱۴. Role of Catheter Ablation in Arrhythmogenic Right Ventricular Cardiomyopathy
۱۵. Arrhythmogenic Right Ventricular Cardiomyopathy Research. Better Together
۱۶. The Role of Protein Redistribution in the Diagnosis of Arrhythmogenic Cardiomyopathy. A
۱۷. The Zurich ARVC Program